These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1253 related articles for article (PubMed ID: 29372247)

  • 21. Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants.
    von der Brelie C; Doukas A; Naumann R; Dempfle A; Larsen N; Synowitz M; Jansen O; Mehdorn M; Jadik S
    Acta Neurochir (Wien); 2017 Jan; 159(1):101-109. PubMed ID: 27873051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage.
    Chen SJ; Yeh SJ; Tang SC; Lin SY; Tsai LK; Jeng JS
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):106-112. PubMed ID: 30876786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
    Boulouis G; Morotti A; Pasi M; Goldstein JN; Gurol ME; Charidimou A
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):263-270. PubMed ID: 29030422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage.
    Lioutas VA; Goyal N; Katsanos AH; Krogias C; Zand R; Sharma VK; Varelas P; Malhotra K; Paciaroni M; Sharaf A; Chang J; Karapanayiotides T; Kargiotis O; Pappa A; Mai J; Pandhi A; Schroeder C; Tsantes A; Mehta C; Kerro A; Khan A; Mitsias PD; Selim MH; Alexandrov AV; Tsivgoulis G
    Stroke; 2018 Oct; 49(10):2309-2316. PubMed ID: 30355114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
    Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
    Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
    Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI; Sayers M; Lip GY; Lane DA
    Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation.
    Chao TF; Chiang CE; Chan YH; Liao JN; Chen TJ; Lip GYH; Chen SA
    Heart Rhythm; 2021 Jun; 18(6):871-877. PubMed ID: 33640447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use.
    Seiffge DJ; Goeldlin MB; Tatlisumak T; Lyrer P; Fischer U; Engelter ST; Werring DJ
    J Neurol; 2019 Dec; 266(12):3126-3135. PubMed ID: 31541341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants.
    Marques-Matos C; Alves JN; Marto JP; Ribeiro JA; Monteiro A; Araújo J; Silva F; Grenho F; Viana-Baptista M; Sargento-Freitas J; Pinho J; Azevedo E
    Int J Stroke; 2017 Aug; 12(6):623-627. PubMed ID: 27903938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardioversion of atrial fibrillation in a real-world setting: non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin.
    Frederiksen AS; Albertsen AE; Christesen AMS; Vinter N; Frost L; Møller DS
    Europace; 2018 Jul; 20(7):1078-1085. PubMed ID: 28655151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
    Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y;
    J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.
    Forslund T; Wettermark B; Andersen M; Hjemdahl P
    Europace; 2018 Mar; 20(3):420-428. PubMed ID: 28177459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness and safety of non-vitamin-K antagonist oral anticoagulants and warfarin in older adults with atrial fibrillation and diabetes.
    Korgaonkar S; Yang Y; Banahan B; Bentley JP
    Curr Med Res Opin; 2021 Mar; 37(3):343-356. PubMed ID: 33327796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use.
    Curtze S; Strbian D; Meretoja A; Putaala J; Eriksson H; Haapaniemi E; Mustanoja S; Sairanen T; Satopää J; Silvennoinen H; Niemelä M; Kaste M; Tatlisumak T
    Eur J Neurol; 2014 Apr; 21(4):616-22. PubMed ID: 24447727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: Insights from a nationwide cohort.
    Butt JH; Li A; Xian Y; Peterson ED; Garcia D; Torp-Pedersen C; Køber L; Fosbøl EL
    Am Heart J; 2019 Oct; 216():117-124. PubMed ID: 31425898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.